Printer Friendly Version
Jim Peterka is co-chair of Locke Lord's IP Pharmaceutical and Biotechnology group, and focuses his practice primarily on Hatch-Waxman pharmaceutical patent litigation. Jim regularly counsels generic pharmaceutical and biotechnology companies in connection with patent issues and in all aspects of patent litigation. His Hatch-Waxman experience ranges from pre-litigation activities, including patent design-around and invalidity counseling and preparation of Paragraph IV notice letters, through discovery, claim construction proceedings, trial, and appeal. He also represents clients in connection with a variety of FDA regulatory issues.
News, Events, Notable Matters, and More
Showing Results for
Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.